CSIMarket


Harvard Bioscience Inc  (HBIO)
Other Ticker:  
 


 

Harvard Bioscience Inc

HBIO's Financial Statements and Analysis



Harvard Bioscience Inc reported in II. Quarter net earnings per share of $0.06 an improvement compare to net loss per share of $-0.01 recorded a year ago and an improvement compare to net loss per share of $-0.17 realized in previous quarter.


II. Quarter
Earnings Per Share Revenues
$ 0.06 $  29 Mill
$+0.07     Unch.     +0.04 %



Harvard Bioscience Inc's Revenue rose by 0.04 % in II. Quarter (Jun 30 2022) year on year, to $29 million and advanced by 1.49 % sequentially.


Harvard Bioscience Inc is Expected to report next financial results on November 04, 2022.

More on HBIO's Income Statement



Harvard Bioscience Inc's net income of $2.435 million in II. Quarter increased from net loss of $-0.410 million II. Quarter a year ago.

Sequentially Company turn into Profitability from net loss of $-6.880 million recorded in previous quarter.

More on HBIO's Growth

Inventories grew by 18.73 % to $29 million from II. Quarter a year ago, sequentially inventories rose by 2.18 %. In II. Quarter company's net cash and cash equivalents decreased by $-1 million, capital expenditures fell by 114.56%, to $-0 millions compare to same quarter a year ago and rose by -6.16% from I. Quarter (Mar 31 2022).

More on HBIO's Cash flow Statement


Harvard Bioscience Inc does not pay out common stock dividend.

In trailing twelve-month period Harvard Bioscience Inc payed $ -0.06 cash per share, on a free-cash flow basis .

Book value fell by -1.72 % sequentially to $1.82 per share, -36.88% of net loss per share in trailing twelve-month period were subtructed from shareholder value.
Tangible Book value grew to $ -0.07 per share from $ -0.17.

Company issued 1.34 million shares or 3.25 % in II. Quarter.


More on HBIO's Dividends

 Market Capitalization (Millions) 140
 Shares Outstanding (Millions) 43
 Total Debt (Millions $) 48
 Revenue (TTM) (Millions $) 121
 Net Income (TTM) (Millions $) -4
 Cash Flow (TTM) (Millions $) -2
 Capital Exp. (TTM) (Millions $) -2
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ -




Harvard Bioscience Inc does not pay out common stock dividend.

In trailing twelve-month period Harvard Bioscience Inc payed $ -0.06 cash per share, on a free-cash flow basis .

Book value fell by -1.72 % sequentially to $1.82 per share, -36.88% of net loss per share in trailing twelve-month period were subtructed from shareholder value.
Tangible Book value grew to $ -0.07 per share from $ -0.17.

Company issued 1.34 million shares or 3.25 % in II. Quarter.


More on HBIO's Balance Sheets

 Market Capitalization (Millions) 140
 Shares Outstanding (Millions) 43
 Total Debt (Millions $) 48
 Revenue (TTM) (Millions $) 121
 Net Income (TTM) (Millions $) -4
 Cash Flow (TTM) (Millions $) -2
 Capital Exp. (TTM) (Millions $) -2
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ -


   



       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

YUMC's Profile

Stock Price

YUMC's Financials

Business Description

Fundamentals

Charts & Quotes

YUMC's News

Suppliers

YUMC's Competitors

Customers & Markets

Economic Indicators

YUMC's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071